In addition, our study also showed that the KRAS mutation-positive group had the largest tumor size (2.83 ± 6.87 cm3) relative to ALK (1.23 ± 3.38 cm3) and EGFR (0.51 ± 2.68 cm3) mutation groups. This evidence concerns the gene KRAS and neoplasm.